SPARKS, Nevada, October 17, 2017 /PRNewswire/ --
RESTANCE, Inc. (USOTC: ANCE) today announced plans to open a condommanufacturing plant in Kenya to produce condoms for all Africa. Research and Markets reports the global condom market is expected to reach US $9.6 Billion
RESTANCE is pursuing several business lines in the growing economies of East Africa. The Company is developing opportunities in the region including initiatives in technology and systems integration services, utility support services, affordable housing and health products manufacturing. RESTANCE recently acquired East African Development Partners as part of its strategy in East Africa.
Learn more about the RESTANCE operations in Africa on the Company's website:http://www.restanceinc.com
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.
Randell Torno firstname.lastname@example.org +1-800-834-5792
SOURCE RESTANCE, Inc.
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All